Latest News
Nabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein Design
Harvard spinout Nabla Bio nabs $11M for AI-driven antibody design
Nabla Bio raises $11M for an “end-to-end” antibody design platform
Nabla Bio Closes $11M Seed Financing led by Khosla Ventures and Zetta Venture Partners